摘要 |
A compound of formula (I) wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NO-mediated diseases such as adult respiratory distress syndrome, cardiovascular ischemia, myocarditis, heart failure, synovitis, shock, diabetes, diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, glomerulonephritis, peptic ulcer, inflammatory bowel disease, cerebral infarction, cerebral ischemia, cerebral hemorrhage, migraine, rheumatoid arthritis, gout, neuritis, postherpetic neuralgia, osteoarthritis, osteoporosis, systemic lupus erythematosus, rejection by organ transplantation, asthma, metastasis, Alzheimer's disease, arthritis, CNS disorders, dermatitis, hepatitis, liver cirrhosis, multiple sclerosis, pancreatitis, atherosclerosis, and the like in human being and animals. 00000 |
申请人 |
FUJISAWA PHARMACEUTICAL CO., LTD.;YATABE, YOSHIKO +HF;ITOH, YOSHIKUNI;INOUE, TAKAYUKI;HAMASHIMA, HITOSHI;SHIMA, ICHIRO;OHNE, KAZUHIKO;YOSHIHARA, KOUSEI;OKU, TERUO |
发明人 |
YATABE, TAKUMI +DI;ITOH, YOSHIKUNI;INOUE, TAKAYUKI;HAMASHIMA, HITOSHI;SHIMA, ICHIRO;OHNE, KAZUHIKO;YOSHIHARA, KOUSEI;OKU, TERUO |